Ascend Wellness Holdings (AAWH) Cash from Operations (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Cash from Operations came in at 19411000.0 in Q1 2026, down 426.84% year-on-year from 5939000.0 in Q1 2025, and down 218.97% quarter-over-quarter from 16316000.0 in Q4 2025.
Ascend Wellness Holdings (AAWH) Cash from Operations (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Cash from Operations history runs 7 years deep, the most recent figure standing at 19411000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations fell 426.84% year-over-year to 19411000.0 in Q1 2026; TTM through Mar 2026 was 12703000.0, a 83.14% decrease from a year earlier, with the FY2025 full-year figure at 38053000.0, down 48.08% from the prior year.
- Cash from Operations retreated to 19411000.0 in Q1 2026 per AAWH's latest filing, from 16316000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 35166000.0 in Q4 2024 and bottomed at 19411000.0 in Q1 2026.
- The 5-year median for Cash from Operations is 5778000.0 (2023), against an average of 7583058.82.
- Across the five-year window, Cash from Operations soared 1644.44% in 2023 and sank 426.84% in 2026, its largest moves.
- Year by year, Cash from Operations stood at 16071000.0 in 2022, then soared by 203.71% to 16668000.0 in 2023, then jumped by 110.98% to 35166000.0 in 2024, then tumbled by 53.6% to 16316000.0 in 2025, then tumbled by 218.97% to 19411000.0 in 2026.
- Per Business Quant, the three latest AAWH Cash from Operations figures stand at 19411000.0 (Q1 2026), 16316000.0 (Q4 2025), and 2003000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | -19.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.41 Mn |
| Mar 31, 2026 | -19.41 Mn |
| Dec 31, 2025 | 16.32 Mn |
| Dec 31, 2025 | 16.32 Mn |
| Sep 30, 2025 | -2.00 Mn |
| Sep 30, 2025 | -2.00 Mn |
| Jun 30, 2025 | 17.80 Mn |
| Jun 30, 2025 | 17.80 Mn |
| Mar 31, 2025 | 5.94 Mn |
| Mar 31, 2025 | 5.94 Mn |
| Dec 31, 2024 | 35.17 Mn |
| Dec 31, 2024 | 35.17 Mn |
| Sep 30, 2024 | 1.97 Mn |
| Sep 30, 2024 | 1.97 Mn |
| Jun 30, 2024 | 32.25 Mn |
| Jun 30, 2024 | 32.25 Mn |
| Mar 31, 2024 | 3.90 Mn |
| Mar 31, 2024 | 3.90 Mn |
| Dec 31, 2023 | 16.67 Mn |
| Dec 31, 2023 | 16.67 Mn |